Fast Field Cycling Imaging of Kidney Disease
Kidney Diseases
About this trial
This is an interventional basic science trial for Kidney Diseases focused on measuring Kidney diseases, Fast Field-Cycling imaging
Eligibility Criteria
Inclusion Criteria: All participants: Participants must be aged 18 and above Participants who meet the safety criteria for undergoing an MRI scan. Participants who can pass through a 50 cm-diameter circular hoop to ensure they will be able to fit inside the scanner Participants must be able to give fully informed consent. Participants must be mobile enough to be positioned onto the FFC-MRI scanner couch. Native kidney damage patients: Patients referred for a kidney biopsy and laboratory evidence (blood tests and urine abnormalities) of kidney impairment. Patients who are newly referred. Transplant patients: Patients with functioning kidney transplant undergoing a kidney biopsy as a part of routine clinical care. Patients who are newly referred. Live donors • Live kidney donors, patients investigated for potential kidney donation and deemed suitable for donation. Exclusion Criteria: Native kidney Damage Patients: Patients with single native kidney. Patients on dialysis. Transplant patients: • Patients with non-functioning kidney transplant. Live donors • Live donors who deemed unsuitable for kidney donation by the living kidney donation clinic. All participants: MRI-incompatible conditions, as detected in the MRI safety screening sheet. Participants under 18 years old. Participants who are unable to give fully informed consent. Women who are pregnant. Restrictions to mobility that would prevent the correct positioning in the scanner. Participants who suffer from claustrophobia. Body mass index larger than 34, due to the limited bore size of the scanner. Participants who are unable to communicate in English.
Sites / Locations
- NHS GrampianRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Live donors
Native kidney damage
Kidney transplants
Live kidney donors (healthy volunteers).
Patients with native kidney damage (suspected active glomerular or interstitial lesion).
Patients with kidney transplant.